(Q43588161)
Statements
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study (English)
R A Appell
P Sand
R Dmochowski
R Anderson
N Zinner
D Lama
M Roach
J Miklos
D Saltzstein
T Boone
D R Staskin
D Albrecht
Overactive Bladder: Judging Effective Control and Treatment Study Group